US stocks advanced bolstered by gains in healthcare shares after the collapse of the $US160 billion ($A212.30 billion) merger of Pfizer and Allergan, and by a rise in energy shares.
US stocks advanced bolstered by gains in healthcare shares after the collapse of the $US160 billion ($A212.30 billion) merger of Pfizer and Allergan, and by a rise in energy shares.